New York State Common Retirement Fund’s ChemoCentryx, Inc. CCXI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-46,272
| Closed | -$2.39M | – | 3280 |
|
|
2022
Q3 | $2.39M | Buy |
46,272
+2,183
| +5% | +$90.2K | ﹤0.01% | 1519 |
|
|
2022
Q2 | $1.09M | Sell |
44,089
-75,856
| -63% | -$1.67M | ﹤0.01% | 1968 |
|
|
2022
Q1 | $3.01M | Buy |
119,945
+56,227
| +88% | +$1.58M | ﹤0.01% | 1545 |
|
|
2021
Q4 | $2.32M | Buy |
63,718
+24,752
| +64% | +$869K | ﹤0.01% | 1692 |
|
|
2021
Q3 | $666K | Sell |
38,966
-6,154
| -14% | -$95.9K | ﹤0.01% | 2316 |
|
|
2021
Q2 | $604K | Buy |
45,120
+420
| +0.9% | +$10.3K | ﹤0.01% | 2495 |
|
|
2021
Q1 | $2.29M | Hold |
44,700
| – | – | ﹤0.01% | 1698 |
|
|
2020
Q4 | $2.77M | Buy |
44,700
+2,100
| +5% | +$120K | ﹤0.01% | 1522 |
|
|
2020
Q3 | $2.33M | Buy |
42,600
+1,800
| +4% | +$96.9K | ﹤0.01% | 1490 |
|
|
2020
Q2 | $2.35M | Buy |
40,800
+4,000
| +11% | +$218K | ﹤0.01% | 1463 |
|
|
2020
Q1 | $1.48M | Hold |
36,800
| – | – | ﹤0.01% | 1549 |
|
|
2019
Q4 | $1.46M | Sell |
36,800
-4,800
| -12% | -$84.3K | ﹤0.01% | 1771 |
|
|
2019
Q3 | $282K | Hold |
41,600
| – | – | ﹤0.01% | 2602 |
|
|
2019
Q2 | $387K | Buy |
41,600
+16,200
| +64% | +$188K | ﹤0.01% | 2500 |
|
|
2019
Q1 | $353K | Hold |
25,400
| – | – | ﹤0.01% | 2466 |
|
|
2018
Q4 | $277K | Hold |
25,400
| – | – | ﹤0.01% | 2561 |
|
|
2018
Q3 | $321K | Sell |
25,400
-11,100
| -30% | -$134K | ﹤0.01% | 2616 |
|
|
2018
Q2 | $481K | Sell |
36,500
-600
| -2% | -$7.18K | ﹤0.01% | 2471 |
|
|
2018
Q1 | $505K | Hold |
37,100
| – | – | ﹤0.01% | 2351 |
|
|
2017
Q4 | $221K | Sell |
37,100
-5,664
| -13% | -$38.9K | ﹤0.01% | 2715 |
|
|
2017
Q3 | $317K | Buy |
42,764
+5,664
| +15% | +$47.1K | ﹤0.01% | 2583 |
|
|
2017
Q2 | $347K | Buy |
37,100
+11,399
| +44% | +$83.7K | ﹤0.01% | 2594 |
|
|
2017
Q1 | $187K | Buy |
25,701
+4,101
| +19% | +$29.5K | ﹤0.01% | 2791 |
|
|
2016
Q4 | $160K | Buy |
21,600
+11,100
| +106% | +$79.9K | ﹤0.01% | 2849 |
|
|
2016
Q3 | $63K | Hold |
10,500
| – | – | ﹤0.01% | 3063 |
|
|
2016
Q2 | $47K | Sell |
10,500
-15,000
| -59% | -$56.3K | ﹤0.01% | 3093 |
|
|
2016
Q1 | $63K | Hold |
25,500
| – | – | ﹤0.01% | 3023 |
|
|
2015
Q4 | $207K | Hold |
25,500
| – | – | ﹤0.01% | 2751 |
|
|
2015
Q3 | $154K | Sell |
25,500
-5,340
| -17% | -$38.6K | ﹤0.01% | 2900 |
|
|
2015
Q2 | $254K | Buy |
+30,840
| New | +$245K | ﹤0.01% | 2826 |
|
Other funds holding CCXI
New York State Common Retirement Fund's CCXI Position: Q4 2022 in Review
New York State Common Retirement Fund sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 46,272 shares — an estimated $2.39M sold.
New York State Common Retirement Fund first reported a position in CCXI in Q2 2015 and held it in 30 quarters. The position peaked at $3.01M in Q1 2022. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.
- New York State Common Retirement Fund reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
- New York State Common Retirement Fund sold 46,272 ChemoCentryx, Inc. shares in Q4 2022, an estimated $2.39M.
- New York State Common Retirement Fund first reported a position in ChemoCentryx, Inc. in Q2 2015 and held it in 30 quarters.
- New York State Common Retirement Fund's ChemoCentryx, Inc. position peaked at $3.01M in Q1 2022.
- 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.
Based on New York State Common Retirement Fund's 13F filing for Q4 2022, filed 30 Jan 2023.